Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major...
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Top Publications
Wadia, U, Soon, W, Chivers, P, Thambiran, A, Burgner, D, Cherian, S, Siafarikas, A.
Randomised Controlled Trial Comparing Daily Versus Depot Vitamin D3 Therapy in 0-16-Year-Old Newly Settled Refugees in Western Australia Over a Period of 40 Weeks..
Nutrients
10(3)
:
2018
view publication
Leentjens, J, Bekkering, S, Joosten, LAB, Netea, MG, Burgner, DP, Riksen, NP.
Trained Innate Immunity as a Novel Mechanism Linking Infection and the Development of Atherosclerosis..
Circ Res
122(5)
:
664 -669
2018
view publication
de Jong, E, Hancock, DG, Hibbert, J, Wells, C, Richmond, P, Simmer, K, Burgner, D, Strunk, T, Currie, AJ.
Identification of generic and pathogen-specific cord blood monocyte transcriptomes reveals a largely conserved response in preterm and term newborn infants..
J Mol Med (Berl)
96(2)
:
147 -157
2018
view publication
Phuong, LK, Curtis, N, Gowdie, P, Akikusa, J, Burgner, D.
Treatment Options for Resistant Kawasaki Disease..
Paediatr Drugs
20(1)
:
59 -80
2018
view publication
Burgner, DP, Miller, JE, Strunk, T, Nassar, N.
Growth Parameters, Effect Measure Modification and the Association Between Vaccination and Early Childhood Hospitalization With Non-targeted Infections..
Clin Infect Dis
66(2)
:
318 -319
2018
view publication